Illnesses and conditions

Scientists have developed a nasal 'molecular shield' that disarms pollen, blocking allergic reactions fast without the use of drugs. This non-invasive method to effectively silence hay fever could be a game changer for around 81 million Americans.

By age 50, you have a 50/50 chance of your gut being primed for developing diverticulitis, a painful condition that sends 200,000 Americans to hospital each year. But the good news is, you can reduce your risk with even just one lifestyle tweak.

The fungus thought to have claimed the lives of several excavators at Tutankhamun's burial site has had an image makeover, with scientists discovering that it holds potent cancer-fighting properties. It opens the door to new fungi-based medicines.

A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use an automated insulin delivery system. It’s hoped this will lead to the approval of Ozempic for this patient population.

A new drug from pharma company Amgen shows promise as a powerful treatment for obesity. With just a once-monthly shot of 'MariTide,' participants in the study lost as much as 16% of their body weight over the course of a year.

Water-based exercise not only improved muscle strength in people with chronic low back pain, but it also improved quality of life, according to a new study. Aquatic therapy could be a viable alternative for those who fear moving or exercising due to pain.

If you have a high level of interaction with patients, students, clients or the general public in your work, you might be at much higher risk of developing type 2 diabetes. And, if you also have poor support at work, it could worsen your odds further.

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the common side effects associated with other therapies.

Over the weekend, Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing what appears to be a strategic "something for everyone" plan of attack from the pharmaceutical giant.

A novel weight loss drug in the same class as semaglutide has successfully met its targets in the largest clinical trial yet, with nearly 90% of participants losing at least 5% of their body weight. The results strengthen its case for FDA approval.

Researchers have analyzed clinical trial data and ranked 12 different non-drug physical therapy treatments for knee osteoarthritis, based on their effectiveness in reducing pain and stiffness, and improving physical function.

Researchers have identified a protein that represses the activity of energy-burning brown fat. The discovery opens the door to developing treatments for the extreme weight loss, muscle wasting, and malnutrition seen in some types of cancer.

Soft corals produce chemicals that could be used to treat human disease. Now, scientists have identified the genes that make these important chemicals, opening the door to creating a limitless supply that can be used to produce and test new drugs.

As unspent antibiotics pass from our bodies, they contribute to the development of antibiotic-resistant bacteria. Scientists are addressing this problem with a new technology which causes such drugs to only become active upon exposure to green light.

A promising new treatment to combat "undruggable" cancers has been green-lit for a human trial. It's hoped the novel drug will be able to stunt the growth and enable the effective treatment of cancers driven by the MYC oncogene and its MYC protein.